2 New Pathology MIPS Measures

pathology mips measures
Facebook
Twitter
LinkedIn

2 New Pathology MIPS Measures
for MSN's CMS Approved QCDR

msn logo

MSN Healthcare Solutions works closely with our pathology partners to develop new MIPS Measures for MSN’s – CMS approved – QCDR.

We were successful in adding the following two measures for 2022: 

  • QMM21:
    Incorporating results of concurrent studies into Final Reports for Bone Marrow Aspirate of patients with Leukemia, Myelodysplastic syndrome, or Chronic Anemia
  • QMM22:
    Multi-gene Next-generation Sequencing Panel Recommended on Fine Needle Aspirations (FNA) of Thyroid Nodule(s) with indeterminate Cytology

MSN Healthcare Solutions is a national provider of pathology billing and revenue cycle services. If your current service contract is up for renewal, why not spend a few minutes with us to discuss how our services may benefit your practice.

CONTACT US ABOUT OUR PATHOLOGY SERVICES



MSN Healthcare solutions areas of operation maps